We independently evaluate all of our recommendations. If you click on links we provide, we may receive compensation. Myles is a former senior insurance editor for Investopedia. He oversaw the strategy ...
The Clorox Company trades at a 17x forward P/E, 20% below the S&P 500, but I see fair value closer to $80 per share. CLX boasts strong brands, competitive margins, and a history of shareholder returns ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback